Eplus Inc: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 8, 2023 and accepted by EDGAR at Nov 7, 2023, 17:54 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $587.6m | us-gaap:Revenues |
| Revenue | 6 months2023-04-01 to 2023-09-30 | $1.16bn | us-gaap:Revenues |
| Cost of revenue | 3 months2023-07-01 to 2023-09-30 | $443.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-04-01 to 2023-09-30 | $875.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-07-01 to 2023-09-30 | $144.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-04-01 to 2023-09-30 | $286.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-07-01 to 2023-09-30 | $92.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-04-01 to 2023-09-30 | $182.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-07-01 to 2023-09-30 | $44.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-04-01 to 2023-09-30 | $91.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-07-01 to 2023-09-30 | $1.2m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-04-01 to 2023-09-30 | $2.1m | us-gaap:InterestExpense |
| Income tax | 3 months2023-07-01 to 2023-09-30 | $12.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-04-01 to 2023-09-30 | $25.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | $32.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-04-01 to 2023-09-30 | $66.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-01 to 2023-09-30 | $1.22 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-04-01 to 2023-09-30 | $2.49 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-01 to 2023-09-30 | $1.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-04-01 to 2023-09-30 | $2.50 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 26,679,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-04-01 to 2023-09-30 | 26,659,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-04-01 to 2023-09-30 | $10.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 6 months2023-04-01 to 2023-09-30 | $8.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-09-30 | $82.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $1.27bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $1.62bn | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $700.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-09-30 | $773.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-09-30 | $845.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001140361-23-051930. Last ingested by Listed: Nov 5, 2026, 19:56 ET. Listed shows no prices and gives no investment advice.